BioPharma

30 March, 2026 | Monday | News

Lonza Expands Bioprocessing Capabilities With Media Development Lab In Singapore

New media development services designed to optimize cell culture media development and identify robust, scalable media formulations driving cell culture performance and reliability The offering is ...

Lab

01 April, 2026 | Wednesday | News

Roche Secures FDA Clearance For Cobas c 703 And Cobas ISE Neo Analytical Units

The cobas® c 703 and cobas® ISE neo analytical units deliver higher testing capacity and increased automation, helping to improve laboratory workflows and advance patient care. High-throughput effici...

BioTech

01 April, 2026 | Wednesday | News

Thermo Fisher Scientific Launches Gibco CHOvantage GS Cell Line Development Kit To Accelerate Biologics Development

Gibco CHOvantage GS Cell Line Development Kit delivers high productivity, streamlined timelines and royalty-free, clinical-stage licensing options to support scalable manufacturing  Thermo Fisher Scientif...

Contract Services

02 April, 2026 | Thursday | News

Samsung Biologics Completes Rockville Facility Acquisition To Expand U.S. Manufacturing Footprint

Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics' geographical diversification and establishes its first U.S. manufacturing presence, expanding regi...

Consumer Health

31 March, 2026 | Tuesday | News

Aroa Biosurgery Reports Positive Primary Endpoint Achievement In Symphony RCT For Diabetic Foot Ulcers

Aroa Biosurgery Limited announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint. Symphony is AROA...

Medtech

27 March, 2026 | Friday | News

Infosys To Acquire Optimum Healthcare IT To Strengthen AI Led Healthcare Transformation

Acquisition to unlock AI-powered cloud and digital transformation for healthcare providers  Infosys  a global leader in next-generation digital services and consulting,  announced a definitive a...

Cell & Gene

02 April, 2026 | Thursday | News

NJ Bio And Ajinomoto Bio-Pharma Services Collaborate To Expand AJICAP Access For ADC Development

NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma Services ("Aji Bio‑Pharma"), a leading provider of biopharmaceutical manufacturing serv...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close